Abstract
Of 50 patients transplanted in the chronic phase of chronic granulocytic leukaemia (CGL), 38 (76%) survive without evidence of leukaemia. One of these patients had Ph′+ve marrow metaphases one year post-transplant that have now disappeared. The actuarial 3-year survival for these patients is 72%. This contrasts with results of transplanting 18 patients in later phases of CGL: only 6 survive and the actuarial 3-year survival is 24%.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
